Four times a year, the DKTK Munich Cancer Colloquia bring together the oncologic community in Munich to exchange updates on the latest research developments. Participants also receive news on DKTK and discuss ongoing activities. 
All members of DKTK Munich and its partner institutes are welcome to attend. 

• 17:30 - 17:55
  Synthetic Biology-Engineered CAR-iNKT and CAR-γδ T cells for Anticancer Immunotherapy: 
  A Systematic Multi-Modal CRISPR Discovery Approach
  Dr. med. Alexander Biederstädt
  Emmy Noether Research Group Leader
  Department of Medicine III, TranslaTUM, TUM University Hospital 

• 17:55 - 18:20
  Decoding and targeting the PDAC ecosystem (DEFEAT-PDAC)
  Prof. Dieter Saur
  Institute of Translational Cancer Research and Experimental Cancer Therapy, DKTK Professorship
  TranslaTUM, TUM Klinikum Rechts der Isar
• 18:20 - 18:30
  Impact of the bone marrow microenvironment on AML treatment outcome
  Dr. Jennifer Rivière
  Götze lab, Department of Medicine III, TUM University Hospital 
  Project funded by Wilko Weichert Grant (2024)
• 18:30 - 19:00
  DKTK News

Zoom-Meeting ID: 618 5229 2497        Kenncode: DKTK72MCC

https://dkfz-de.zoom-x.de/j/61852292497?pwd=w9H5aFlKRXk0JACvtR33bq6U0TVtwa.1 

key words: gastrology, immunotherapy, genomics, haematology